Table 1.

CD2 Differentially Affects the Proportions of Thymocyte Subsets in TCR Transgenic Mice

MutationNo. Thymocytes × 10−7 (Mean ± SEM)Percent of Total Thymocytes (mean ± SEM)
CD48CD4+8+CD4+8CD48+
H-Y 9.8 ± 0.3 15 ± 1.7 61 ± 3.0 8.5 ± 1.0 16 ± 1.2 
H-Y/CD2o 9.5 ± 1.5 15 ± 1.6 46 ± 3.7 8.2 ± 0.2 31 ± 3.2 
2C 1.8 ± 0.5 51 ± 0.6 19 ± 2.0 9.4 ± 1.7 21 ± 1.8 
2C/CD2o 1.9 ± 0.4 56 ± 2.6 13 ± 2.3 9.7 ± 1.2 21 ± 1.3 
MutationNo. Thymocytes × 10−7 (Mean ± SEM)Percent of Total Thymocytes (mean ± SEM)
CD48CD4+8+CD4+8CD48+
H-Y 9.8 ± 0.3 15 ± 1.7 61 ± 3.0 8.5 ± 1.0 16 ± 1.2 
H-Y/CD2o 9.5 ± 1.5 15 ± 1.6 46 ± 3.7 8.2 ± 0.2 31 ± 3.2 
2C 1.8 ± 0.5 51 ± 0.6 19 ± 2.0 9.4 ± 1.7 21 ± 1.8 
2C/CD2o 1.9 ± 0.4 56 ± 2.6 13 ± 2.3 9.7 ± 1.2 21 ± 1.3 

Five mice (6 to 12 weeks old) were analyzed per group. Thymocytes from the indicated TCR transgenic mice were stained with phycoerythrin-labeled anti-CD4 and fluorescein isothiocyanate-labeled anti-CD8 MoAbs and analyzed in the FACScan flow cytometer. The total number of viable thymocytes recovered from these transgenic lines are indicated.

Close Modal

or Create an Account

Close Modal
Close Modal